Put him on ignore... everybody! Then he is shoveling his sht with nobody listening. And don't comment back to him. Just keeps him going. Put him on ignore.
Correct, it was released by the AAIC conference site for the Alzheimer's conference in Toronto. BETTER than if the company had. I believe this just surfaced in the past day. So what do you think, the data is going to be bad??? Hardly. Never heard of a one-hour presentation (from 1-2PM 7/27) it says. That's' a biggie.
I guy on the iHub board was supposed to be there. Maybe some post over there. Clearly it was still not the 12 week data. Geez... No word on attending the ACIC meeting in Canada in July on the web site events so far.
Holy cow... even the improved form takes 45 minutes to fill oui??? Are you sh@#&ting me???! ... for each patient??
" It is much shorter than the form previously used for individual patient expanded access requests and is designed specifically for these requests. It should take about 45 minutes for a physician to complete the new form. " Isn't there some procedure whereby the drug can just be opened up to access by anybody ahead to time under the same circumstance (no current cure available) as in this procedure for expanded us. procedure, so you dont; have to file a 45 minute form for EACH patient. Holy crapper!
Came out 5/26 if you missed it. In lieu of the link since Yahoo doesn't like them- Google on "bionap" click on the link to Jason Napodano's site and scroll down recent articles, should be the second or third one down. Good job.
I just want somebody to ask why trial enlistments are so slow and what this might imply to uptake once approved and how big the market really is.. Simple questions. PLEASE, somebody that attends please ask. And InVivo please address this regardless if asked. It is the #1 thing everybody wants to know.
Did I miss something? Stock keeps rebounding up and not sure what is driving it.
Did anybody attend? Have notes to share?
The most glaring thing I got out of reviewing the presentation was no mention whatsover on slide 31, or was it 32, of finding a Big Pharma partner being on their to do list. How could that not be on that slide/list?
NVEE trades 85,000 shares a day which equates to over $2 million in volume. That's not too bad. The price action makes no sense to me, though the market has been selling off pretty hard the past two days. I don't know why anybody would sell this one though.